[(18)F]Fluorodeoxyglucose-positron emission tomography/computed tomography response evaluation can predict histological response at surgery after induction chemotherapy for oligometastatic bladder cancer.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Kollberg, PetterAlmquist, Helen
Bläckberg, Mats
Cwikiel, Magdalena
Gudjonsson, Sigurdur
Lyttkens, Kerstin
Patschan, Oliver
Liedberg, Fredrik
Issue Date
2017-08
Metadata
Show full item recordCitation
[(18)F]Fluorodeoxyglucose-positron emission tomography/computed tomography response evaluation can predict histological response at surgery after induction chemotherapy for oligometastatic bladder cancer. 2017, 51 (4):308-313 Scand J UrolAbstract
Patients with limited metastatic and locally advanced bladder cancer have a poor prognosis, and no definite treatment recommendations exist. However, long-term survival is possible for selected patients if surgery is combined with multiple courses of chemotherapy (i.e. induction chemotherapy). Patients with tumours that are insensitive to chemotherapy probably have little to gain from subsequent extensive surgery. The aim of this study was to evaluate sequential FDG-PET/CT examinations as an indicator of chemotherapy response.Between 2007 and 2015, 50 patients with oligometastatic invasive bladder cancer selected for induction chemotherapy underwent two FDG-PET/CT examinations: the first before the start of chemotherapy and the second after three courses of cisplatinum-based combination chemotherapy. Responders were given up to six courses of chemotherapy. FDG-PET/CT response was correlated with histological response in excised lymph-node metastases.
Three patients showed progression to incurable disease during chemotherapy and another two patients did not undergo surgery, for medical reasons. Lymphadenectomy was performed in the remaining 45 patients, of whom 43 had lymph-node metastasis. FDG-PET/CT prediction of the histological nodal chemotherapy response was correct in 37 (86%) of those 43. The second FDG-PET/CT examination identified four out of nine non-responders. For response, the sensitivity, specificity, and positive and negative predictive values for FDG-PET/CT accuracy were 37 out of 37 (100%), one out of six (17%), 37 out of 42 (88%) and one out of one (100%), respectively.
Repeated FDG-PET/CT seems to predict histological response. However, with the histological response criteria used in this study, five non-responders were not identified by the second FDG-PET/CT investigation.
Description
To access publisher's full text version of this article click on the hyperlink belowAdditional Links
http://www.tandfonline.com/doi/full/10.1080/21681805.2017.1321579?scroll=top&needAccess=trueRights
Archived with thanks to Scandinavian journal of urologyae974a485f413a2113503eed53cd6c53
10.1080/21681805.2017.1321579
Scopus Count
Collections
Related articles
- FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy.
- Authors: van de Putte EEF, Vegt E, Mertens LS, Bruining A, Hendricksen K, van der Heijden MS, Horenblas S, van Rhijn BWG
- Issue date: 2017 Sep
- Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy.
- Authors: Rouanne M, Girma A, Neuzillet Y, Vilain D, Radulescu C, Letang N, Yonneau L, Hervé JM, Botto H, Le Stanc E, Lebret T
- Issue date: 2014 Dec
- Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinoma.
- Authors: Giannatempo P, Alessi A, Miceli R, Raggi D, Farè E, Nicolai N, Serafini G, Padovano B, Piva L, Biasoni D, Torelli T, Catanzaro M, Stagni S, Maffezzini M, Mariani L, Gianni AM, Sonpavde G, Salvioni R, Necchi A, Crippa F
- Issue date: 2014 Dec
- Is [F-18]-fluorodeoxyglucose FDG-PET/CT better than ct alone for the preoperative lymph node staging of muscle invasive bladder cancer?
- Authors: Uttam M, Pravin N, Anish B, Nandita K, Arup M
- Issue date: 2016 Mar-Apr
- FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
- Authors: Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, Werbrouck P
- Issue date: 2010 Apr